Review



22k operon v2 1 human genome oligo microarray chip  (GE Healthcare)


Bioz Verified Symbol GE Healthcare is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GE Healthcare 22k operon v2 1 human genome oligo microarray chip
    Comparison of mRNA expression in seven candidate genes between TPCH test (n = 30, <t>microarray)</t> and training set (n = 62 qRT-PCR data), with two public microarray datasets of lung tissue samples (Spira et al , , n = 34; and Golpon et al , n = 10) . Fold change represents mean expression ratio of moderate versus mild emphysema (TPCH training set), severe/mild emphysema versus normal (Spira et al ), or severe emphysema versus normal samples (Golpon et al ). The absence of a bar indicates the gene was not represented on the microarray platform.
    22k Operon V2 1 Human Genome Oligo Microarray Chip, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/22k+operon+v2+1+human+genome+oligo+microarray+chip/pmc02746189-65-27-18?v=GE+Healthcare
    Average 90 stars, based on 3 article reviews
    22k operon v2 1 human genome oligo microarray chip - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Expression profiling identifies genes involved in emphysema severity"

    Article Title: Expression profiling identifies genes involved in emphysema severity

    Journal: Respiratory Research

    doi: 10.1186/1465-9921-10-81

    Comparison of mRNA expression in seven candidate genes between TPCH test (n = 30, microarray) and training set (n = 62 qRT-PCR data), with two public microarray datasets of lung tissue samples (Spira et al , , n = 34; and Golpon et al , n = 10) . Fold change represents mean expression ratio of moderate versus mild emphysema (TPCH training set), severe/mild emphysema versus normal (Spira et al ), or severe emphysema versus normal samples (Golpon et al ). The absence of a bar indicates the gene was not represented on the microarray platform.
    Figure Legend Snippet: Comparison of mRNA expression in seven candidate genes between TPCH test (n = 30, microarray) and training set (n = 62 qRT-PCR data), with two public microarray datasets of lung tissue samples (Spira et al , , n = 34; and Golpon et al , n = 10) . Fold change represents mean expression ratio of moderate versus mild emphysema (TPCH training set), severe/mild emphysema versus normal (Spira et al ), or severe emphysema versus normal samples (Golpon et al ). The absence of a bar indicates the gene was not represented on the microarray platform.

    Techniques Used: Expressing, Microarray, Quantitative RT-PCR



    Similar Products

    90
    GE Healthcare 22k operon v2 1 human genome oligo microarray chip
    Comparison of mRNA expression in seven candidate genes between TPCH test (n = 30, <t>microarray)</t> and training set (n = 62 qRT-PCR data), with two public microarray datasets of lung tissue samples (Spira et al , , n = 34; and Golpon et al , n = 10) . Fold change represents mean expression ratio of moderate versus mild emphysema (TPCH training set), severe/mild emphysema versus normal (Spira et al ), or severe emphysema versus normal samples (Golpon et al ). The absence of a bar indicates the gene was not represented on the microarray platform.
    22k Operon V2 1 Human Genome Oligo Microarray Chip, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/22k+operon+v2+1+human+genome+oligo+microarray+chip/pmc02746189-65-27-18?v=GE+Healthcare
    Average 90 stars, based on 1 article reviews
    22k operon v2 1 human genome oligo microarray chip - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Comparison of mRNA expression in seven candidate genes between TPCH test (n = 30, microarray) and training set (n = 62 qRT-PCR data), with two public microarray datasets of lung tissue samples (Spira et al , , n = 34; and Golpon et al , n = 10) . Fold change represents mean expression ratio of moderate versus mild emphysema (TPCH training set), severe/mild emphysema versus normal (Spira et al ), or severe emphysema versus normal samples (Golpon et al ). The absence of a bar indicates the gene was not represented on the microarray platform.

    Journal: Respiratory Research

    Article Title: Expression profiling identifies genes involved in emphysema severity

    doi: 10.1186/1465-9921-10-81

    Figure Lengend Snippet: Comparison of mRNA expression in seven candidate genes between TPCH test (n = 30, microarray) and training set (n = 62 qRT-PCR data), with two public microarray datasets of lung tissue samples (Spira et al , , n = 34; and Golpon et al , n = 10) . Fold change represents mean expression ratio of moderate versus mild emphysema (TPCH training set), severe/mild emphysema versus normal (Spira et al ), or severe emphysema versus normal samples (Golpon et al ). The absence of a bar indicates the gene was not represented on the microarray platform.

    Article Snippet: Lung and universal reference RNA (Stratagene, La Jolla, CA, USA) was reverse transcribed, labeled with Cy5 and Cy3 (Amersham/GE Healthcare, Buckinghamshire, England) respectively and co-hybridized onto a 22K Operon V2.1 Human Genome Oligo Microarray chip http://www.operon.com containing 21,329 70 mer probes representing ~14,200 named transcripts printed by the British Columbia Gene Array Facility http://www.microarray.prostatecentre.com .

    Techniques: Expressing, Microarray, Quantitative RT-PCR